3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Neoplasm Metastasis
4
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Polycystic Ovary Syndrome
2
Infertility
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Leiomyoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
HR+/HER2- Breast Cancer
1
HER2 Negative Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Ductal
1
Breast Neoplasm Female
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Anovulation
1
Anatomic Stage II Breast Cancer AJCC v8
1
Advanced HR+/HER2- Breast Cancer
1
Interventions
Bevacizumab
12
olaparib
10
Paclitaxel
10
Carboplatin
10
liposomal doxorubicin
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
6
mirvetuximab soravtansine
4
Topotecan
4
Taxes
4
Immunoglobulin G
4
Gemcitabine
4
Disulfides
4
Biopsy
4
pembrolizumab
3
cediranib
3
Oxaliplatin
2
Doxorubicin
2
1-dodecylpyridoxal
2
tremelimumab
1
trastuzumab deruxtecan
1
sotorasib
1
sarilumab
1
palbociclib
1
niraparib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
ipatasertib
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Letrozole
×
30 days
×
Clear all
No trials found.